Actively Recruiting
Study of Combined Trans-Perineal Prostate Biopsy and Laser Ablation for Men with Severe Urinary Symptoms and Low to Intermediate Risk Prostate Cancer
Led by Benha University · Updated on 2026-09-30
30
Participants Needed
1
Research Sites
1 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a combined procedure called Bioblation for men with severe lower urinary tract symptoms LUTS who are suspected to have low to favorable intermediate-risk prostate cancer. This study aims to validate the safety and clinical outcomes of performing a trans-perineal prostate biopsy and laser ablation during the same session to reduce the need for multiple interventions and provide early symptom relief. The Bioblation procedure is done under local anesthesia and involves taking biopsy samples guided by ultrasound followed immediately by targeted laser ablation of the tumor using an MRI-guided system. The study includes patients with specific prostate cancer risk profiles and severe LUTS, and it focuses on a single treatment session designed to combine diagnosis and therapy efficiently. Participants will be monitored over 12 months with assessments including symptom scores, urinary flow rates, prostate volume, and PSA levels at baseline and multiple follow-up points. Researchers will also track any procedure-related complications during this period. This comprehensive follow-up aims to evaluate both urinary symptom improvement and oncological safety after the combined biopsy and ablation treatment.
CONDITIONS
Brief Title
Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer
Research Team
A
Ahmed Mohamed AL-Lithi, MBBCh Medical Degree
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here